Clinical Trials

Showing 341 - 360 of 485 trials
Titlesort icon Investigator Disease(s)
A Phase Ib Study of MDX-1106 (BMS-936558) in Combination with Ipilimumab (BMS-734016) in Patients with Unresectable Stage III or Stage IV Malignant Melanoma
[Protocol 09-155]
Wolchok, Jedd
  • Melanoma
A Phase IB Study of LEE011 and Exemestane with and without Everolimus in Women with Locally Advanced or Metastatic Breast Cancer
[Protocol 13-179]
Modi, Shanu
  • Breast Cancer
A Phase Ib Study of ARN-509 plus Everolimus in Men with Progressive Metastatic Castration-Resistant Prostate Cancer After Abiraterone Therapy
[Protocol 13-025]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase Ib Study of AEB071 and MEK162 in Patients with Advanced Uveal Melanoma
[Protocol 13-172]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase IA/B Study of CC-115 in Castration-Resistant Prostate Cancer
[Protocol 12-080]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I/IIA Study of Dabrafenib in Children with Advanced BRAF Mutation-Positive Solid Tumors
[Protocol 13-016]
Pratilas, Christine
  • Melanoma
  • Pediatric Brain Tumors
  • Solid Tumors
A Phase I/IIA Study of Carfilzomib plus High-Dose Melphalan Before Autologous Stem Cell Transplant in Patients with Multiple Myeloma
[Protocol 12-144]
Landau, Heather
  • Hematology
    • Multiple Myeloma
A Phase I/IIa Study of Alpharadin® Plus Docetaxel in Patients with Bone Metastases from Castration-Resistant Prostate Cancer
[Protocol 10-086]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I/II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin's Lymphoma
Newly Diagnosed
[Protocol 11-013]
Noy, Ariela
  • AIDS-Associated Cancers
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies
[Protocol 06-125]
Boulad, Farid
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase I/II Study of Veliparib (ABT-888) Given with Radiation Therapy and then Given with Temozolomide in Children with Newly Diagnosed Diffuse Pontine Glioma
Newly Diagnosed
[Protocol 12-176]
Gilheeney, Stephen
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
[Protocol 95-024]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Blood and Marrow Transplantation
    • Transplantation
  • Leukemia
  • Lymphoma
A Phase I/II Study of the ALK Inhibitor CH5424802 in Patients with ALK-Rearranged Non-Small Cell Lung Cancer
[Protocol 12-113]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of Sunitinib in Young Patients with Advanced Gastrointestinal Stromal Tumors
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-226]
Magnan, Heather
  • Sarcomas
    • Soft Tissue Sarcoma
  • Upper Gastrointestinal
A Phase I/II Study of Sequential Chemoradiation Followed by Autologous Stem Cell Transplant in Patients with Untreated Advanced Mantle Cell Lymphoma
Newly Diagnosed
[Protocol 11-095]
Zelenetz, Andrew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of SC16LD6.5 in Patients with Recurrent Small Cell Lung Cancer
[Protocol 13-184]
Pietanza, M. Catherine
  • Lung Cancer, Small Cell
A Phase I/II Study of PLX3397 to Treat Patients with Acute Myeloid Leukemia that Has Returned or Persisted Despite Therapy
Relapsed/Refractory
[Protocol 13-204]
Stein, Eytan
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I/II Study of Paclitaxel, Cisplatin, and ABT-888 (Velaparib) to Treat Advanced, Persistent, or Recurrent Cervical Cancer
[Protocol 11-131]
Leitao, Mario
  • Cervical Cancer
A Phase I/II Study of Oral Azacitidine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes after Receiving a Stem Cell Transplant from a Donor
[Protocol 13-160]
Papadopoulos, Esperanza
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I/II Study of Nivolumab Alone and with Ipilimumab in Patients with Advanced or Metastatic Solid Tumors
Relapsed/Refractory
[Protocol 13-187]
Callahan, Margaret
  • Breast Cancer
  • Lung Cancer, Non-Small Cell
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer